Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9DEX

Crystal structure of human peroxiredoxin 1 in complex with inhibitor WF-097

Summary for 9DEX
Entry DOI10.2210/pdb9dex/pdb
DescriptorPeroxiredoxin-1, 1,2-ETHANEDIOL, SULFATE ION, ... (6 entities in total)
Functional Keywordshuman peroxiredoxin 1, oxidoreductase, covalent inhibitor complex
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight45931.95
Authors
Lowther, W.T.,Gumpena, R. (deposition date: 2024-08-29, release date: 2025-10-29, Last modification date: 2025-11-19)
Primary citationNelson, K.J.,Smalley Jr., T.L.,Messier, T.,Gumpena, R.,Gandhi, U.,Milczarek, S.,Habibovic, A.,Hoffman, H.,Gibson, V.,Hondal, R.J.,Lowther, W.T.,Cunniff, B.
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy.
Sci Adv, 11:eady4492-eady4492, 2025
Cited by
PubMed Abstract: Covalent inhibitors that are approved and marketed drugs exploit a wide array of warheads and reactions with amino acid side chain-based nucleophiles. Thiostrepton (TS) inhibits the peroxidase activity of the mitochondrial antioxidant protein peroxiredoxin 3 by forming a covalent crosslink between the two active site cysteine residues. Peroxiredoxin 3 inactivation increases reactive oxygen species levels, induces cancer cell death in preclinical models, and shows promise in an ongoing clinical trial for malignant mesothelioma using direct pleural infusion. We report the identification of the minimal fragment of TS that contains tandem dehydro-alanine (DHA) moieties and maintains anticancer activity while losing interactions with three alternative targets of intact TS. Biochemical, kinetic, cellular, and structural studies demonstrate that this fragment is a mechanism-based peroxiredoxin inhibitor. These findings represent a promising start toward a pro-oxidant approach for cancer therapy. Moreover, the data support that the DHA moiety should be added to the covalent warhead arsenal.
PubMed: 41171914
DOI: 10.1126/sciadv.ady4492
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

245011

数据于2025-11-19公开中

PDB statisticsPDBj update infoContact PDBjnumon